Faculty of Pharmaceutical Sciences

• Collaboration for Outcomes Research and Evaluation
• Molecular and Systems Pharmacology
• Nanomedicine and Chemical Biology
• Pharmacy Education Research and Leadership

By the Numbers

2024 QS World University Rankings, Pharmacy & Pharmacology: #35 Worldwide, #2 in Canada

As of Jan 2024 (from Jul 1, 2022 to Dec 31, 2023)

• Publications: 190
• Grants: 160 (active, non-internal, Fiscal Apr 1, 2022–Mar 31, 2023)
• Awards: 13 
• Presentations: 41
• Media Hits: 92
• Students
  • E2P PharmD: 861 (Jan 1–Apr 28, 2023); 635 (May 15–Aug 19, 2023); 888 (Sep 1–Dec 22, 2023)
  • Flex PharmD: 19 (Jan 1–Apr 28, 2023); 17 (May 15–Aug 19, 2023); 17 (Sep 1–Dec 22, 2023)
  • BPSc: 150 (Jan 1–Apr 28, 2023); 64 (May 15–Aug 19, 2023); 198 (Sep 1–Dec 22, 2023)
  • MSc: 40
  • PhD: 50
  • Postdoctoral Research Fellows: 31
  • Visiting International Research Students: 13
  • 4,329 registrants in 14 Continuing Pharmacy Professional Development programs and 95 Canadian Pharmacy Practice Program
• Alumni (total): 7,489
• Experiential Education: 795 Practice Educators in 532 Practice Sites
• Practice: 3,492 Patient Encounters (Jul 1, 2022–Dec 31, 2023); 25,946 Patient Encounters (cumulative total through 122 months of operation)
• People: 80 Total FTE Faculty; 664 Clinical Faculty; 30 Honorary Faculty; 107 Total Staff; 4 Research Associates; 151 Student Workers

To view our 2023 Year in Review report, click here (PDF, 5.2 MB).

June 2024

Manon Jaffredo, Nicole A. J. Krentz, Benoite Champon, Claire E. Duff, Sameena Nawaz, Nicola Beer, Christian Honore, Anne Clark, Patrik Rorsman, Jochen Lang, Anna L. Gloyn, Matthieu Raoux, Benoit Hastoy; Electrophysiological characterisation of iPSC-derived human β-like cells and an SLC30A8 disease model. Diabetes 2024; db230776.

Kathryn Richardson, Yoon Kong Loke, Helen I McDonald, Helen Mary Parretti, Fawziah Marra. Herpes zoster vaccine and the risk of stroke: a population-based cohort study using linked data from the Clinical Practice Research Datalink. BMJ Public Health 2024;2:e000671. doi:10.1136/bmjph-2023-000671.

MacDonald BJ, Wang EHZ, Turgeon RD. Research and scholarly methods: Appraising the available literature to inform a research project. J Am Coll Clin Pharm 2024 (online). Available at: https://doi.org/10.1002/jac5.1987.

Krol ES, Velazquez-Martínez CA, Jurgens TM, Albon SP. Medicinal chemistry curriculum and pedagogical practices at Canadian pharmacy schools: Towards standardization of practice. Currents in Pharmacy Teaching and Learning. 2024;16: Article 102105. doi: https://doi.org/10.1016/j.cptl.2024.04.011

Barry AR, Helisaz H, Safari A, Loewen P. Effect of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers after coronary artery bypass graft surgery: a population-based cohort study. J Am Heart Assoc; published online June 6, 2024. Link: https://doi.org/10.1161/JAHA.124.035215

Barry AR. Risk assessment in ASCVD. In: Jackevicius C, Patterson JH, eds. Cardiology Self-Assessment Program, 2024 Book 1, Atherosclerotic Cardiovascular Disease. Lenexa, KS: American College of Clinical Pharmacy, 2024, 7-24.

Barry AR. Dyslipidemia and statin therapy in patients with HIV. Pharmacy Practice + Business 2024;11(1):27-8.

Domanski N, Leung C. Flip the Script: Changing Documentation Standards and Establishing Best Practices for Pharmacists in a Primary Care Setting. INNOVATIONS in pharmacy. 2024;15(2):7-7. doi:10.24926/iip.v15i2.6147 https://pubs.lib.umn.edu/index.php/innovations/article/view/6147/3616

Lee CS, Shang R, Wang F, Khayambashi P, Wang H, Araujo G, Puri K, Vlodavsky I, Hussein B, Rodrigues B. Heparanase Stimulation of Physiological Cardiac Hypertrophy is Suppressed Following Chronic Diabetes Resulting in Cardiac Remodeling and Dysfunction. Diabetes. 2024 May 21:db240217. doi: 10.2337/db24-0217

June 2024

Finbloom, Joel, Microbe-Interfacing Nanomaterials to Study Bacteria-Material Interactions and Biofilm Behaviour*, 2024 Discovery Grants, 2024 NSERC Discovery Research Program.

Velenosi, Thomas, Co-applicant: Rodrigues, Brian, Developing tools for stable-isotope tracing lipidomics that will investigate cardiac lipid metabolism, 2024 Discovery Horizons Grant, 2024 NSERC Discovery Research Program.

Dr. Larry Lynd is a co-investigator on The Rare Disease Administrative Data Research (RADAR) Team who has been awarded a CIHR Improving Health and Administrative Data and Monitoring for Rare Diseases Team Grant of $1.6 million over four years. This research aims to fill the gap in identifying rare disease patients in administrative data, describe their medical needs, and understand the importance of patient and family participation in registries. This information will be used to monitor the health system, improve quality, and inform health research and policy decisions.

Williams, Karla, Detection and Categorization of Cancers using Nanoaperture Optical Trapping of Single Extracellular Vesicles, $250,000, NFRF 2023 Exploration Stream.

Vu, Ly, Decoding cell fate regulatory networks through single cell omics and modelling approaches, $250,000, NFRF 2023 Exploration Stream.

Reinforcement of Education for Nephrology Academic Learning (RENAL) Project. Rim M (Student Partner). $500. UBC Students as Partners (SaP) Dissemination Fund. May 2024. (Faculty Partner: Dr. Fong Chan).

Reinforcement of Education for Nephrology Academic Learning (RENAL) Project. Luong I (Student Partner). $500. UBC Students as Partners (SaP) Dissemination Fund. May 2024. (Faculty Partner: Dr. Fong Chan).

Collaborating with First Nations Communities to Address Medication Appropriateness and Priorities for Medication Safety. CIHR Planning and Dissemination Grant. $25,000. PI: McDonald EG. Co-I's: Leung L, Min J, Ruben A, Sadowski C, Thompson W.